The accumulation of neutrophils at sites of tissue injury or infection is mediated by chemotactic factors released as part of the inflammatory process. Some of these factors are generated as a direct consequence of tissue injury or infection, including degradation fragments of connective tissue collagen and bacterial- or viral-derived peptides containing collagen-related structural motifs. In these studies, we examined biochemical mechanisms mediating the biologic activity of synthetic polypeptides consisting of repeated units of proline (Pro), glycine (Gly), and hydroxyproline (Hyp), major amino acids found within mammalian and bacterial collagens. We found that the peptides were chemoattractants for neutrophils. Moreover, their chemotactic potency was directly related to their size and composition. Thus, the pentameric peptides (Pro-Pro-Gly)5 and (Pro-Hyp-Gly)5 were more active in inducing chemotaxis than the corresponding decameric peptides (Pro-Pro-Gly)10 and (Pro-Hyp-Gly)10. In addition, the presence of Hyp in peptides reduced chemotactic activity. The synthetic peptides were also found to reduce neutrophil apoptosis. In contrast to chemotaxis, this activity was independent of peptide size or composition. The effects of the peptides on both chemotaxis and apoptosis were blocked by inhibitors of phosphatidylinositol 3-kinase (PI3-K) and p38 mitogen-activated protein (MAP) kinase. However, only (Pro-Pro-Gly)5 and (Pro-Pro-Gly)10 induced expression of PI3-K and phosphorylation of p38 MAP kinase, suggesting a potential mechanism underlying reduced chemotactic activity of Hyp-containing peptides. Although none of the synthetic peptides tested had any effect on intracellular calcium mobilization, each induced nuclear binding activity of the transcription factor NF-kappa B. These findings indicate that polymeric polypeptides containing Gly-X-Y collagen-related structural motifs promote inflammation by inducing chemotaxis and blocking apoptosis. However, distinct calcium-independent signaling pathways appear to be involved in these activities.
The accumulation of neutrophils at sites of tissue injury or infection is mediated by chemotactic factors released as part of the inflammatory process. Some of these factors are generated as a direct consequence of tissue injury or infection, including degradation fragments of connective tissue collagen and bacterial- or viral-derived peptides containing collagen-related structural motifs. In these studies, we examined biochemical mechanisms mediating the biologic activity of synthetic polypeptides consisting of repeated units of proline (Pro), glycine (Gly), and hydroxyproline (Hyp), major amino acids found within mammalian and bacterial collagens. We found that the peptides were chemoattractants for neutrophils. Moreover, their chemotactic potency was directly related to their size and composition. Thus, the pentameric peptides(Pro-Pro-Gly)5 and (Pro-Hyp-Gly)5 were more active in inducing chemotaxis than the corresponding decameric peptides (Pro-Pro-Gly)10 and (Pro-Hyp-Gly)10. In addition, the presence of Hyp in peptides reduced chemotactic activity. The synthetic peptides were also found to reduce neutrophil apoptosis. In contrast to chemotaxis, this activity was independent of peptide size or composition. The effects of the peptides on both chemotaxis and apoptosis were blocked by inhibitors of phosphatidylinositol 3-kinase (PI3-K) and p38 mitogen-activated protein (MAP) kinase. However, only (Pro-Pro-Gly)5 and (Pro-Pro-Gly)10 induced expression of PI3-K and phosphorylation of p38 MAP kinase, suggesting a potential mechanism underlying reduced chemotactic activity of Hyp-containing peptides. Although none of the synthetic peptides tested had any effect on intracellular calcium mobilization, each induced nuclear binding activity of the transcription factor NF-kappa B. These findings indicate that polymeric polypeptides containing Gly-X-Y collagen-related structural motifs promote inflammation by inducing chemotaxis and blocking apoptosis. However, distinct calcium-independent signaling pathways appear to be involved in these activities.
The inflammatory response is
characterized by an accumulation of
neutrophils at sites of tissue injury and infection. Neutrophils
respond to chemotactic factors including connective tissue
degradation products, leukotriene B4, and bacterially-derived
formylmethionine-leucine-phenylalanine (fMLP), released from
damaged tissue or by invading pathogens. In previous studies we
demonstrated that collagenase or cyanogen bromide digests of
native collagen, as well as synthetic collagen-like polypeptides
containing glycine (Gly), proline (Pro), and hydroxyproline (Hyp)
are potent chemoattractants for human neutrophils [1,
2, 3].
These polypeptides also activated macrophages to release
neutrophil chemokines [4]. The present studies were aimed at
analyzing mechanisms mediating the biological activity of collagen
degradation products using synthetic polypeptides as a model.
Synthetic polypeptides are similar to degradation products
generated from mammalian collagen and/or to collagen-related
structural motifs produced by bacteria and viruses [5]. The
use of synthetic model peptides of varying length and composition
allowed us to perform structure-activity studies.Chemoattractants such as fMLP and interleukin-8 (IL-8) initiate
their biological activity by binding to specific cell surface
receptors. For most chemoattractants, this is followed by
mobilization of intracellular calcium, activation of protein
kinases, and translocation and binding of transcription factors
to consensus sequences in promoter regions of genes regulating
the inflammatory response [6, 7,
8]. We speculated that
variations in the activity of the synthetic peptides may be
related to their distinct ability to activate these signaling
pathways.
METHODS
Reagents
The synthetic polypeptides(Pro-Pro-Gly)5,
(Pro-Pro-Gly)10, (Pro-Hyp-Gly)5, and (Pro-Hyp-Gly)10
were purchased from Peptides International (Louisville,
Ky). Hanks' balanced salt solution (HBSS) and fMLP were
obtained from Sigma (St Louis, Mo). LY 294002 was from Calbiochem
(La Jolla, Calif) and SB 203580 from Biomol (Plymouth Meeting,
Pa). Indo-1 acetoxymethyl ester (Indo-1 AM) was purchased from
Molecular Probes (Eugene, Ore) and stored as a 1 mM stock
solution in dimethylsufoxide at −20°C. Rabbit
polyclonal antibodies against NF-κB-p50,
NF-κB-p65, and p38 MAP kinase, as well as
horseradish peroxidase-(HRP-)linked secondary antibodies, were
from Santa Cruz Biotechnology (Santa Cruz, Calif). Mouse
monoclonal anti-phospho-p38 MAP kinase (Thr180/Tyr182) antibody
(IgG1) was purchased from Cell Signaling Technology (Beverly,
Mass), and mouse monoclonal anti-phosphatidylinositol 3-kinase
(PI3-K) (p85-subunit-reactive) antibody from BD Biosciences
PharMingen (San Diego, Calif). Double-stranded DNA probes used
for electrophoretic mobility shift assays (EMSAs) were obtained
from IDT Technologies (Coralville, Iowa). FITC-linked Annexin V
was from R & D Systems (Minneapolis, Minn), and propidium iodide
from Calbiochem (San Diego, Calif).
Cell isolation
Human neutrophils were isolated from
heparinized peripheral venous blood by dextran sedimentation and
Ficoll density gradient centrifugation as previously described
[9]. These studies were approved by the Institutional Review
Board of UMDNJ Robert Wood Johnson Medical School.
Measurement of chemotaxis
Migration of neutrophils through nucleopore polycarbonate filters
was assayed using the modified Boyden chamber technique
[10]. For our studies we used a 48-well microchemotaxis
chamber (Neuro Probe, Inc, Pleasanton, Calif). Thirty microliters
of synthetic peptides, fMLP (5 × 10−8 M), or medium
control were placed in each well of the lower chamber. A 5-μm
pore-size filter was then placed over the wells and the upper
chamber set into place. Fifty microliters of a neutrophil
suspension (1 × 105cells) in HBSS containing 0.5%
bovine serum albumin (BSA) and 2.4 mg/ml HEPES, pH 7.2, was
added to each well. After incubation for 45 minutes at
37°C, the filter containing adhered, migrated neutrophils
was removed and stained with Wright-Giemsa. Chemotaxis was
quantified as the number of cells that migrated through the
filter in 10 oil immersion fields. In some experiments, cells
were incubated at room temperature with LY 294002 (50 μM,
5 minutes) or SB 203580 (30 μM, 1 hour) prior to
the analysis of chemotactic responsiveness.
Measurement of intracellular calcium
Indo-1 AM was used to measure intracellular calcium mobilization
[11]. Neutrophils were inoculated into Nunc coverglass
chambers (2 × 106 cells/chamber) and allowed to
adhere overnight. Cells were then washed with HBSS containing
0.3% BSA and incubated in 1 μM Indo-1 AM at
37°C. After 30 minutes, the cells were washed three
times and 1 mL of HBSS containing 0.3% BSA was added to
each well. Intracellular calcium was quantified on a Meridian
ACAS 570 Anchored Cell Analysis System (Okemos, Mich) equipped
with an Innova 90 5-W laser adjusted to an output of 100 mW.
For measurement of cellular fluorescence, Indo-1 was excited using
the ultraviolet lines (351–364 nm) of the argon laser.
Calcium mobilization was quantified by scanning single 130 × 130 μm fields containing ≥ 15 cells every
8 seconds for a total of 5 minutes and collecting the
emissions at 485 nm (calcium-free Indo-1) and 405 nm
(calcium-saturated Indo-1). Data are presented as the ratio of
emission at 405 nm relative to 485 nm. Synthetic peptides
(10 nM) or fMLP (5 × 10−8 M) were added to the
cells 180 seconds after stable baselines were established.
Western blot analysis
Neutrophils were incubated (37°C) with medium control,
fMLP (5 × 10−8 M), or 10 nM (Pro-Pro-Gly)5,
(Pro-Pro-Gly)10, (Pro-Hyp-Gly)5, or (Pro-Hyp-Gly)10
for 2 hours (PI3-K) or 5 minutes (p38, phospho-p38). Cells
were then solubilized in buffer containing 50 mM HEPES, pH 7.4,
10 mM KCl, 1 mM EDTA, 1 mM DTT, 1 μg/mL
pepstatin A, 1 μg/mL leupeptin, 10 μg/mL
soybean
trypsin inhibitor, 10 μg/mL aprotinin, and 1%
Triton X-100. After 10 minutes in ice, lysates were
centrifuged (4000 xg, 5 minutes) and protein concentrations
in the supernatants were quantified using a BCA Protein Assay Kit
(Pierce, Rockford, Ill) with BSA as the standard. Aliquots of
supernatants containing 10 μg of protein were
fractionated on 7.5% SDSpolyacrylamide gels and
electroblotted onto 0.45 μm nitrocellulose paper
(Bio-Rad, Hercules, Calif) at 250 mA for 4 hours in a
Mini Trans-Blot Electrophoretic Transfer Cell (Bio-Rad) in
25 mM Tris, pH 8.3, 192 mM Gly, 20% (v/v) methanol.
Blots
were then incubated in a 1 : 250 dilution of
anti-phospho-p38 MAP kinase antibody, anti-p38 MAP kinase, or
anti-PI3-K antibody. After washing, the blots were incubated with
goat antimouse IgG (1 : 2000) or sheep antirabbit IgG (1 : 1000)
HRP-conjugated antibodies for 1 hour at room temperature.
Proteins were detected using a Renaissance Western Blot
Chemiluminescence Reagent Plus kit (NEN Life Sciences, Boston,
Mass).
Measurement of neutrophil apoptosis
Neutrophils were
washed in PBS, resuspended in Dulbecco's Modified Eagle's Medium
(DMEM) containing 10% fetal bovine serum, and incubated in a
shaking water bath at 37°C for 24 hours in the presence or
absence of peptides (10 nM). Cells were then centrifuged,
resuspended (2 × 106 cells/mL) in binding buffer
(10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM
CaCl2), and incubated (15 minutes, room temperature) with
Annexin V and propidium iodide. Samples were analyzed by flow
cytometry on a Coulter EPICS Profile II (Hialeah, Fla). Viable,
apoptotic, and necrotic neutrophil populations were gated
electronically and data analyzed using quadrant statistics based
on relative Annexin V and propidium iodide fluorescence [12].
Electrophoretic mobility shift assay
To prepare nuclear extracts, neutrophils (2 × 106) were
microcentrifuged for 15 seconds and then resuspended in
400 μL of cold buffer (10 mM HEPES, pH 7.9, 10 mM
KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM
PMSF). After 15 minutes in ice, 25 μL of a
10% solution of NP-40 was added, and the sample mixed on a
vortex for 10 seconds. The lysates were then centrifuged for
30 seconds in a microfuge, the nuclear pellets resuspended in
50 μL of ice-cold buffer (20 mM HEPES, pH 7.9,
0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM
DTT, 1 mM PMSF) and placed on a rocker platform at 4°C
for 15 minutes. The sample was then microcentrifuged for
5 minutes at 4°C and the resulting soluble nuclear
extracts were collected. Double-stranded probes containing an
NF-κB (AGTTGAGGGGACCGCCCGCGGCCCGT)
consensus sequence were labeled with (γ-32P)-dCTP.
For binding reactions, nuclear extracts (50 μg of
protein) were incubated for 15 minutes at room temperature
with labeled probe in buffer containing 10 mM Tris-HCl, pH
7.4, 40 mM NaCl, 10 mM EDTA, 1 mM
2-mercaptoethanol, 0.1% NP-40, 4% glycerol, and
0.1 μg/μL poly. (dI-dC)poly. (dI-dC)
(Amersham Pharmacia Biotech, Piscataway, NJ). For
competitive binding assays, nuclear extracts were incubated with
a 100-fold excess unlabeled probe. Supershift assays were
performed by incubation of the samples with polyclonal antibodies
to p50 or p65 (1 μg/60 μL reaction volume) for
1 hour prior to the addition of the labeled probe. Samples
were electrophoresed on 4% nondenaturing polyacrylamide gels
in buffer (0.04 M Tris-acetate, 0.001 M EDTA, pH 8.0) at
15 V/cm. Gels were then dried and autoradiographed.
RESULTS
We have previously demonstrated that synthetic
pentameric peptides
consisting of Pro and Gly, or Pro, Hyp, and Gly are
chemoattractants for neutrophils [1, 2,
3].
Figure 1 shows that the chemotactic activity of these
peptides is dose related, reaching a maximum at 10 nM.
Increasing the length of the peptides from five to ten repeated
units reduced their chemotactic activity. At concentrations of 1
and 10 nM, peptides consisting of Pro,
Gly, and Hyp were less
chemotactic than peptides consisting of only Pro and Gly. At
optimal concentrations, (Pro-Pro-Gly)5, the most potent of the
synthetic peptides, was approximately 60% less active than
fMLP in inducing
chemotaxis (data not shown).
Figure 1
Induction of chemotaxis by synthetic
polypeptides. Neutrophil chemotaxis was assayed using microwell
chambers. Each bar represents the mean ± SEM of 3–4
experiments. Background levels of migration were subtracted from
each value. (a) Dose-dependent effects of peptides on neutrophil
chemotaxis. (b) Cells were incubated with medium control, the p38
MAP kinase inhibitor SB 203580 (30 μM, 1 hour) or the
PI3-K inhibitor LY 294002 (50 μM, 5 minutes) prior to
the analysis of chemotactic responsiveness to polypeptides
(10 nM). (Pro-Pro-Gly)n, (PPG)n;
(Pro-Hyp-Gly)n, (POG)n.
Activated neutrophils are cleared from inflamed sites by the
process of apoptosis, followed by macrophage phagocytosis. This
leads to resolution rather than persistence of tissue injury.
Chemoattractants such as fMLP promote inflammation by activating
neutrophils and prolonging the survival of these cells in tissues
by blocking apoptosis [13]. In further studies, we analyzed
the effects of synthetic polymeric peptides on neutrophil
apoptosis. One of the earliest signs of apoptosis is
translocation of phosphatidylserine (PS) from the inner to the
outer surface of the plasma membrane, which can be detected by
Annexin V binding [14]. Approximately 30% of neutrophils
was found to undergo spontaneous apoptosis after 24 hours in
culture (Figure 2). This activity was significantly
reduced in the presence of the polypeptides. The effects of the
synthetic peptides were similar to fMLP. In contrast to
chemotaxis, no differences were noted in the antiapoptotic
activity of collagen-like peptides in terms of their size or
composition.
Figure 2
Measurement of neutrophil apoptosis. Cells were
incubated in a shaking water bath (37°C) in the presence or
absence of fMLP (5 × 10−8 M), synthetic
polypeptides, SB 203580, or LY 294002 for 24 hours and then
labeled with Annexin V and propidium iodide and analyzed by flow
cytometry. Data were analyzed using Coulter quadrant statistics
based on relative fluorescence binding of Annexin V and propidium
iodide. Each bar represents the mean ± SEM of 3–4
experiments. Significantly different (P < .05) from
control.
We next investigated potential biochemical signaling pathways
mediating the biologic activity of these peptides in neutrophils.
For comparative purposes, we also evaluated the response of the
cells to fMLP. Treatment of neutrophils with fMLP caused a rapid
and transient increase in intracellular calcium, which was evident
within 30 seconds (Figure 3). In contrast, none of
the synthetic polypeptides induced calcium mobilization in
neutrophils. PI3-K catalyzes the formation of
phosphatidylinositol 3,4,5-triphosphate and plays a key role in
neutrophil activation and chemotaxis [15,
16]. Low levels of
PI3-K protein were detectable in unstimulated neutrophils
(Figure 4a). Treatment of the cells with pentameric
peptides consisting of Pro and Gly resulted in a twofold
increase in PI3-K. This was evident after 2 hours and was
similar to the response observed with fMLP. In contrast, the
pentameric peptide containing Hyp had no effect on PI3-K, and
increasing the length of the peptides from 5 to 10 repeated
units did not alter the quantity of PI3-K detected. To analyze
the role of PI3-K in collagen peptide-induced chemotaxis and
apoptosis, cells were treated with LY 294002 [17]. This
PI3-K inhibitor was found to reduce chemotaxis induced by fMLP,
(Pro-Pro-Gly)5 and (Pro-Pro-Gly)10, as well as
(Pro-Hyp-Gly)5, and (Pro-Hyp-Gly)10 by 50%
(Figure 1b, data not shown). No major
differences were noted in the sensitivity of the peptides to the
PI3-K inhibitor. Similarly, LY 294002 was found to block the
inhibitory effects of both fMLP and synthetic peptides on
apoptosis. As observed with chemotaxis, no differences were
observed in the sensitivity of the antiapoptotic effects of the
peptides to PI3-K inhibition (Figure 2, data not shown).
In the absence of these peptides, LY 294002 had no effect on
chemotaxis or apoptosis.
Figure 3
Effects of synthetic polypeptides on calcium
mobilization. Neutrophils were incubated with Indo-1
(1 μM). After establishing a stable baseline, 10 nM
(Pro-Pro-Gly)5, (Pro-Pro-Gly)10, (Pro-Hyp-Gly)5, or
fMLP was added (arrow) to the cells. Calcium mobilization is
indicated by an increase in the Indo-1 fluorescence ratio. Each
graph represents the average change in ratio in a field containing
not less than 15 cells.
Figure 4
Effects of synthetic polypeptides on PI3-K and p38 MAP
kinase expression. Neutrophils were incubated (37°C) with
medium control, fMLP (5 × 10−8 M), or 10 nM
(Pro-Pro-Gly)5, (Pro-Pro-Gly)10, (Pro-Hyp-Gly)5, or
(Pro-Hyp-Gly)10 for 2 hours (PI3-K) or 5 minutes
(p38, phospho-p38). (a) PI3-K, (b) p38, (c) phospho-p38, (d)
protein expressions were measured using western blotting
and quantified by densitometry. Time course of phospho-p38 protein
expression in response to (Pro-Pro-Gly)5. Western blots were
scanned by densitometry and data presented as relative intensity
units. One representative experiment of 3 is shown for each
analysis.
Recent studies have implicated MAP kinases in
chemoattractant-induced signaling and in PI3-K activation in
neutrophils [18,
19, 20]. We
found that untreated neutrophils
expressed relatively large quantities of total p38 MAP kinase
protein (Figure 4b). Expression of this protein was
unaltered by fMLP or by synthetic polypeptides. In contrast, only
low levels of phospho-p38 MAP kinase were detected in
unstimulated neutrophils, and this was markedly increased in
response to fMLP, as well as (Pro-Pro-Gly)5 and
(Pro-Pro-Gly)10 (Figure 4c). The effects of these
peptides on phospho-p38 expression were rapid, peaking 5
minutes after treatment and persisting for at least 20 minutes
(Figure 4d, data not shown). Treatment of neutrophils
with peptides containing Hyp had no significant effect on
phospho-p38 protein expression (Figure 4c).
Pretreatment of the cells with SB 203580, a p38 MAP kinase
inhibitor [21], was found to significantly reduce chemotaxis
induced by (Pro-Pro-Gly)5 and (Pro-Pro-Gly)10, as well as
(Pro-Hyp-Gly)5, and (Pro-Hyp-Gly)10 (Figure 1b).
Similarly, SB 203580 blocked the effects of fMLP and
synthetic peptides on apoptosis, indicating that this response is
also p38 MAP kinase-dependent
(Figure 2, data not shown).The transcription factor NF-κB is known to be activated by
chemoattractants through MAP kinases [22]. We found that each
of the synthetic peptides, like fMLP, induced nuclear binding of
NF-κB (Figure 5). This response was
independent of peptide length or composition. Supershift assays
revealed that the NF-κB complex contained both p50 and p65 (not
shown). Preincubation of nuclear extracts with excess unlabeled
probe competitively reduced binding of the labeled probe,
demonstrating its specificity.
Figure 5
Effects of synthetic polypeptides on NF-κB
nuclear binding activity. Neutrophils (1 × 106/mL) were
treated with medium control (Med), synthetic peptides
(10 nM), or fMLP (5 × 10−8 M) for
30 minutes. Nuclear extracts (50 μg of protein) were
analyzed for NF-κB binding activity using a gel retardation
assay. Extracts, prepared from fMLP-treated cells were incubated
in ice for 1 hour with antibodies to the p50 or p65
subunits of NF-κB (1 μg), or 100-fold excess
unlabeled cold competitor (Comp) prior to the labeled
probe.
DISCUSSION
Neutrophil chemotaxis and survival are regulated by inflammatory
mediators that are present at sites of infection or injury.
Whereas proinflammatory mediators promote chemotaxis and block
apoptosis, antiinflammatory cytokines are proapoptotic and
abrogate the chemotactic response. Coordinate regulation of
chemotaxis and survival allows for the persistence of neutrophils
at sites of injury, as well as effective termination of the
inflammatory response [23]. The present studies demonstrate
that synthetic peptides containing collagen-like structural motifs
induce chemotaxis and reduce apoptosis in neutrophils. These
results are consistent with a proinflammatory role of these
peptides. This is supported by reports that synthetic
collagen-like peptides also stimulate oxidative metabolism and
macrophage release of neutrophil chemokines [4,
24]. Tissue
injury is associated with breakdown of interstitial connective
tissue. Our findings that peptides containing collagen-like
structural motifs exhibit proinflammatory activity suggests that
they may play a role in amplifying acute immunological responses
to infection or injury.Consistent with previous studies [2,
3], we found that the
chemotactic activity of the synthetic polypeptides was directly
related to their size and composition. Thus, larger peptides
containing ten repeated subunits were less active than those
containing five subunits. Moreover, peptides consisting of Pro,
Gly, and Hyp were less chemotactic than peptides consisting of
only Pro and Gly. In contrast, although each of the peptides
markedly reduced neutrophil apoptosis, these effects were
independent of peptide size or structure. These data suggest
that collagen peptide-induced chemotaxis and apoptosis involve
distinct receptors and/or signaling mechanisms.One early step in the signaling pathway induced by
chemoattractants is mobilization of intracellular Ca++
[25, 26]. In contrast to
fMLP, the synthetic peptides had no
effect on calcium mobilization in human neutrophils. These
findings suggest that the chemotactic and antiapoptotic actions
of these peptides do not require changes in intracellular calcium.
This is consistent with reports of other proinflammatory
mediators that alter neutrophil chemotaxis and apoptosis by
mechanisms independent of intracellular calcium shifts, including
transforming growth factor-β1, soluble Fas ligand, immune
complexes, and the antineutrophil antibody, DL1.2
[27, 28,
29, 30]. Our
findings suggest that the requirement for
increases in intracellular calcium for induction of biological
activity depends on the chemoattractant.Activation of protein kinases including PI3-K and p38 MAP kinase
is thought to play a critical role in chemoattractant-induced
signaling leading to biologic responses
[19, 20,
31, 32,
33, 34,
35, 36]. Consistent
with this idea, we
found that the effects of the synthetic peptides on chemotaxis
and apoptosis were dependent on both PI3-K and p38 MAP kinase
activity. Thus, LY 294002 and SB 203580, inhibitors of PI3-K and
p38 MAP kinase, respectively, blocked both the chemotactic and
antiapoptotic activity of each of the peptides. However, whereas
(Pro-Pro-Gly)5 and (Pro-Pro-Gly)10 induced PI3-K and
phospho-p38 expression in neutrophils, (Pro-Hyp-Gly)5 and
(Pro-Hyp-Gly)10 had no effect on these proteins. Peptides
containing Hyp were also less potent chemoattractants than
peptides containing only Pro and Gly. These findings suggest that
the relative chemotactic potency of these peptides may be related
to their efficacy in upregulating PI3-K and p38 MAP kinase.
Alternatively, fMLP, (Pro-Pro-Gly)5, and (Pro-Pro-Gly)10
may induce rapid alterations in the subcellular localization of
PI3-K protein in neutrophils, leading to increased accessibility
and detection by immunoblotting. In contrast, this does not
appear to be the case for apoptosis. Thus, an inability to induce
PI3-K or phospho-p38 MAP kinase had no effect on the
antiapoptotic activity of Hyp-containing peptides. The
observation that the antiapoptotic effects of (Pro-Hyp-Gly)5
and (Pro-Hyp-Gly)10 were blocked by PI3-K and p38 MAP kinase
inhibitors indicates that these signaling pathways are
nevertheless essential for this response. However, they appear to
be activated distinctly by (Pro-Pro-Gly)n and
(Pro-Hyp-Gly)npeptides.Previous studies have suggested that PI3-K-mediated responses
induced by chemoattractants involve mobilization of intracellular
calcium through activation of phospholipase C [37].
Alterations in cytosolic Ca2+ are also important in
inducing p38 MAP kinase activity in neutrophils [38]. In
contrast, our findings indicate that synthetic peptide-induced
activation of PI3-K and p38 MAP kinase, leading to chemotaxis and
reduced apoptosis, occurs though calcium-independent pathways. It
is possible that phosphoinositides, or phosphorylated protein
products of PI3-K or p38 MAP kinase, interact directly with
actin-binding proteins, resulting in directed migration
of the cells [39]. p38 MAP kinase is also known to
phosphorylate proteins that may regulate chemotaxis
and apoptosis by calcium-independent mechanisms, including
MAP kinase-activated proteins 2, 3, and 5, as well as
the transcription factors ATF-2 and CHOP-1 [40].Signaling via PI3-K and p38 MAP kinase leads to the activation of
the transcription factor NF-κB, which is known to regulate
genes involved in inflammatory responses to tissue injury
[41]. NF-κB has been reported to be involved in
chemoattractant-induced neutrophil activation as well as the
suppression of apoptosis [22, 42].
Moreover, mice lacking the
NF-κB subunit c-Rel are resistant to collagen-induced
arthritis, and inhibition of NF-κB blocks neutrophil
migration into damaged lungs in vivo [43,
44, 45]. We found
that peptides containing collagen-related structural motifs
induced NF-κB nuclear binding activity in neutrophils.
However, no significant differences in activity were observed
based on the size or composition of the peptides. These findings
are consistent with the antiapoptotic effects of these synthetic
peptides and suggest that the chemotactic and antiapoptotic
effects of the peptides involve distinct signaling pathways
leading to NF-κB activation.
CONCLUSIONS
Polymeric polypeptides containing collagen-related structural
motifs promote inflammation by inducing chemotaxis and blocking
apoptosis. However, distinct calcium-independent signaling
pathways appear to be involved in these activities. Neutrophil
chemotaxis and apoptosis are a key to initiating and controlling
inflammation. The accumulation and persistence of these cells in
tissues in response to protein fragments generated by invasive
pathogens or by the degradation of connective tissue collagen may
exacerbate injury. An understanding of the mechanisms mediating
these processes is essential in developing strategies for
limiting maladaptive inflammatory responses.
Authors: C Ward; E R Chilvers; M F Lawson; J G Pryde; S Fujihara; S N Farrow; C Haslett; A G Rossi Journal: J Biol Chem Date: 1999-02-12 Impact factor: 5.157
Authors: Saskia A Overbeek; Paul A J Henricks; Anja I Srienc; Pim J Koelink; Petra de Kruijf; Herman D Lim; Martine J Smit; Guido J R Zaman; Johan Garssen; Frans P Nijkamp; Aletta D Kraneveld; Gert Folkerts Journal: Eur J Pharmacol Date: 2011-03-31 Impact factor: 4.432